| Segment and Geographic Information |
| |
|
Three Months |
|
|
Nine Months |
|
| |
|
Ended |
|
|
Ended |
|
| |
|
December
31, |
|
|
December
31, |
|
| Geographic region |
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
| United States |
|
$ |
1,010,000 |
|
|
$ |
647,000 |
|
|
$ |
2,983,000 |
|
|
$ |
1,358,000 |
|
| Latin America |
|
|
1,261,000 |
|
|
|
1,076,000 |
|
|
|
4,085,000 |
|
|
|
3,336,000 |
|
| Europe and Rest of World |
|
|
1,202,000 |
|
|
|
751,000 |
|
|
|
2,725,000 |
|
|
|
1,977,000 |
|
| |
|
|
3,473,000 |
|
|
|
2,474,000 |
|
|
|
9,793,000 |
|
|
|
6,671,000 |
|
| Product license fees and royalties |
|
|
120,000 |
|
|
|
555,000 |
|
|
|
906,000 |
|
|
|
2,601,000 |
|
| Total product related revenues |
|
$ |
3,593,000 |
|
|
$ |
3,029,000 |
|
|
$ |
10,699,000 |
|
|
$ |
9,272,000 |
|
|
| License fees and royalties by partner |
| |
|
Three Months |
|
|
Nine Months |
|
| |
|
Ended |
|
|
Ended |
|
| |
|
December
31, |
|
|
December
31, |
|
| Partner |
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
| Exeltis (formerly Quinnova) |
|
$ |
44,000 |
|
|
$ |
54,000 |
|
|
$ |
201,000 |
|
|
$ |
361,000 |
|
| Innovacyn |
|
|
– |
|
|
|
123,000 |
|
|
|
29,000 |
|
|
|
1,110,000 |
|
| Laboratorios Sanfer (formerly More Pharma) |
|
|
76,000 |
|
|
|
378,000 |
|
|
|
676,000 |
|
|
|
1,130,000 |
|
| Total product license fees and royalties |
|
$ |
120,000 |
|
|
$ |
555,000 |
|
|
$ |
906,000 |
|
|
$ |
2,601,000 |
|
|